JP2007500707A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500707A5
JP2007500707A5 JP2006522027A JP2006522027A JP2007500707A5 JP 2007500707 A5 JP2007500707 A5 JP 2007500707A5 JP 2006522027 A JP2006522027 A JP 2006522027A JP 2006522027 A JP2006522027 A JP 2006522027A JP 2007500707 A5 JP2007500707 A5 JP 2007500707A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
compound according
pharmaceutically acceptable
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006522027A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/024334 external-priority patent/WO2005012270A2/en
Publication of JP2007500707A publication Critical patent/JP2007500707A/ja
Publication of JP2007500707A5 publication Critical patent/JP2007500707A5/ja
Pending legal-status Critical Current

Links

JP2006522027A 2003-07-29 2004-07-28 ビアリールヘテロ環状のアミン、アミドおよび硫黄−含有化合物、並びに該化合物の製造方法および使用方法 Pending JP2007500707A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49085503P 2003-07-29 2003-07-29
PCT/US2004/024334 WO2005012270A2 (en) 2003-07-29 2004-07-28 Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same

Publications (2)

Publication Number Publication Date
JP2007500707A JP2007500707A (ja) 2007-01-18
JP2007500707A5 true JP2007500707A5 (cg-RX-API-DMAC10.html) 2007-09-06

Family

ID=34115440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006522027A Pending JP2007500707A (ja) 2003-07-29 2004-07-28 ビアリールヘテロ環状のアミン、アミドおよび硫黄−含有化合物、並びに該化合物の製造方法および使用方法

Country Status (4)

Country Link
US (1) US20070197541A1 (cg-RX-API-DMAC10.html)
EP (1) EP1664001A2 (cg-RX-API-DMAC10.html)
JP (1) JP2007500707A (cg-RX-API-DMAC10.html)
WO (1) WO2005012270A2 (cg-RX-API-DMAC10.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012271A2 (en) * 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
TWI454465B (zh) 2003-06-03 2014-10-01 Melinta Therapeutics Inc 聯芳基雜環化合物及製法及其用途
ES2536001T3 (es) * 2003-07-29 2015-05-19 Melinta Therapeutics, Inc. Procedimiento para la síntesis de biariloxazolidinonas
EP1713785A1 (en) 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
EP1706372B1 (en) * 2003-12-22 2010-05-19 Merck Sharp & Dohme Corp. Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
ATE496914T1 (de) 2005-06-08 2011-02-15 Rib X Pharmaceuticals Inc Verfahren zur synthese von triazolen
CN102516115B (zh) * 2006-08-09 2016-05-11 史密丝克莱恩比彻姆公司 作为阿片样物质受体的拮抗剂或反向激动剂的新型化合物
MX2011012627A (es) 2009-05-28 2011-12-14 Novartis Ag Derivados aminobutiricos sustituidos como inhibidores de nepralisina.
JP5420761B2 (ja) 2009-05-28 2014-02-19 ノバルティス アーゲー ネプリリシン阻害剤としての置換アミノプロピオン酸誘導体
KR20120083292A (ko) * 2009-09-16 2012-07-25 아스테라스 세이야쿠 가부시키가이샤 글리신 화합물
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
PE20151666A1 (es) 2013-02-14 2015-11-19 Novartis Ag Derivados sustituidos del acido bisfenil butanoico fosfonico como inhibidores de la nep
KR20150119107A (ko) 2013-02-14 2015-10-23 노파르티스 아게 개선된 생체내 효능을 갖는 nep 억제제로서의 치환된 비스페닐 부탄산 유도체
BR112015023044A8 (pt) 2013-03-15 2021-09-28 Melinta Subsidiary Corp Métodos para tratar infecções em pacientes acima do peso e obesos com o uso de antibióticos
WO2014207708A2 (en) 2013-06-28 2014-12-31 Auckland Uniservices Limited Amino acid and peptide conjugates and conjugation process
WO2016061772A1 (en) 2014-10-22 2016-04-28 Merck Sharp & Dohme Corp. Nargenicin compounds and uses thereof as antibacterial agents
CR20170196A (es) 2014-11-14 2017-07-10 Melinta Therapeutics Inc Método para tratar, prevenir o reducir el riesgo de infección cutánea
CN107250103A (zh) 2014-12-23 2017-10-13 玛格丽特·安妮·布林布尔 氨基酸缀合物和肽缀合物以及其用途
CN107709314A (zh) 2015-06-11 2018-02-16 巴斯利尔药物国际股份公司 外排泵抑制剂及其治疗性用途
TW201735952A (zh) 2016-02-26 2017-10-16 瑪格蕾特 安 布萊博 胺基酸及肽共軛物以及共軛過程
AU2017371362A1 (en) * 2016-12-09 2019-07-25 Celltaxis, Llc Pendant amines and derivatives as inhibitors of leukotriene A4 hydrolase
CN118525002A (zh) 2022-01-14 2024-08-20 恩科化学公司 原卟啉原氧化酶抑制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
TW572757B (en) * 1998-08-24 2004-01-21 Bristol Myers Squibb Co Novel isoxazolinone antibacterial agents
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
CN1433413A (zh) * 2000-06-05 2003-07-30 东亚制药株式会社 新的噁唑烷酮衍生物及其制备方法
WO2005012271A2 (en) * 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
TWI454465B (zh) * 2003-06-03 2014-10-01 Melinta Therapeutics Inc 聯芳基雜環化合物及製法及其用途
ES2536001T3 (es) * 2003-07-29 2015-05-19 Melinta Therapeutics, Inc. Procedimiento para la síntesis de biariloxazolidinonas

Similar Documents

Publication Publication Date Title
JP2007500707A5 (cg-RX-API-DMAC10.html)
JP2007514782A5 (cg-RX-API-DMAC10.html)
JP2013508297A5 (cg-RX-API-DMAC10.html)
RU2005100516A (ru) Производные 2-уреидо-6-гетероарил-3н-бензимидазол-6-карбоновой кислоты и родственные соединения в качестве ингибиторов гиразы и/или топоизомеразы iv для лечения бактериальных инфекций
JP2013508299A5 (cg-RX-API-DMAC10.html)
CA2513463A1 (en) Gyrase inhibitors and uses thereof
JP2013508298A5 (cg-RX-API-DMAC10.html)
JP2004502752A5 (cg-RX-API-DMAC10.html)
JP2005533061A5 (cg-RX-API-DMAC10.html)
RU2009135067A (ru) Производные иминопиридина и их применение в качестве микробиоцидов
RU2008125055A (ru) 2-(фенил или гетероцикло)-1h-фенантро[9.10-d]имидазолы в качестве ингибиторов mpges-1
WO2008117079B1 (en) Antimicrobial compounds based upon 4-aminoquinoline
CA2433197A1 (en) Gyrase inhibitors and uses thereof
CA2631880A1 (en) Chromane substituted benzimidazoles and their use as acid pump inhibitors
JP2013535487A5 (cg-RX-API-DMAC10.html)
JP2003516404A5 (cg-RX-API-DMAC10.html)
JP2008535902A5 (cg-RX-API-DMAC10.html)
JP2009514894A5 (cg-RX-API-DMAC10.html)
RU2013108641A (ru) Способ лечения офтальмологических заболеваний с использованием соединений ингибиторов киназы в пролекарственных формах
TWI444198B (zh) 用於治療革蘭氏陽性菌感染的新穎抗菌劑
RU2004123097A (ru) Бициклические гетероциклические замещенные антибактериальные соединения фенилоксазолидинона и относящиеся к ним композиции и способы
JP2006505543A5 (cg-RX-API-DMAC10.html)
JP2008526999A5 (cg-RX-API-DMAC10.html)
KR20060113625A (ko) 시클로프로필기 치환된 옥사졸리디논 항생제 및 그의유도체
KR20110091504A (ko) 퀴놀론 화합물의 제조 방법